Literature DB >> 16509932

Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.

Kresimir Galesic1, Borka Bozic, Ivana Racic, Mira Scukanec-Spoljar.   

Abstract

The association of interferon (IFN) therapy with haemolytic uraemic syndrome in patients with chronic myeloid leukaemia (CML) has been reported infrequently. The pathogenesis of the renal lesion in such cases remains unclear. We report the case of a patient with chronic myeloid leukaemia who developed nephrotic syndrome and renal failure while being treated with hydroxyurea and IFN-alpha. Renal biopsy showed features of chronic thrombotic microangiopathy. The discontinuation of IFN-alpha, and a prompt institution of plasmapheresis and steroids resulted in improvement of the nephrotic syndrome and renal function. These findings suggest that long-term IFN-alpha therapy can induce thrombotic microangiopathy and haemolytic uraemic syndrome in patients with chronic myeloid leukaemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16509932     DOI: 10.1111/j.1440-1797.2006.00524.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  3 in total

1.  Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report.

Authors:  Haruomi Nishio; Tatsuo Tsukamoto; Takeshi Matsubara; Yoichiro Okada; Ryosuke Takahashi; Motoko Yanagita
Journal:  CEN Case Rep       Date:  2016-06-20

2.  Drug-induced hemolytic uremic syndrome.

Authors:  G Li Cavoli; A Ferrantelli; C Tortorici; L Bono; C Giammarresi; R Passantino; U Rotolo
Journal:  Indian J Nephrol       Date:  2011-04

Review 3.  Adverse Renal Effects of Anticancer Immunotherapy: A Review.

Authors:  Maciej Borówka; Stanisław Łącki-Zynzeling; Michał Nicze; Sylwia Kozak; Jerzy Chudek
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.